Background The application of human epididymis protein 4 (HE4) in diverse health
diseases, especially in cancers, has been extensively studied in recent decades. To …

Background Ovarian cancer (OC) is considered the most lethal gynecological cancer, of
which more than 65% cases are diagnosed in advanced stages, requiring platinum-based …

Introduction Uterine cervical cancer (UCC) is the fourth most common health problem
worldwide among women. Currently available biomarkers CA125, CA199, and CEA for …

Background: Lung cancer is the most common cause of malignant pleural effusion (MPE).
Serum human epididymis secretory protein 4 (HE4) is a useful diagnostic marker for lung …

Differential expressions of genes are widely evaluated for the diagnosis and prognosis
correlations with diseases. But limited studies investigate how transcriptional regulations are …

Objective This study aimed to explore the application value of human epididymis protein 4
(HE4) in diagnosing and monitoring the prognosis of lung cancer. Methods First, TCGA (The …

Early detection of lung cancer allows for earlier stage treatment initiation and improved
patient prognosis. This report focuses on utilization of combining patient demographic …

降低肺癌死亡率最有效的方法是早诊断, 早治疗, 但目前尚未有理想的肺癌筛查和早诊模式.
近年来, 为了提高肺癌的早期诊断率, 降低肺癌患者死亡率, 延长生存期, 越来越多的研究探索 …

BACKGROUND: Patients with non-small cell lung cancer (NSCLC) and stable disease (SD)
have an unmet clinical need to help guide early treatment adjustments. OBJECTIVE: To …

摘要目的: 探讨血清胃泌素释放肽前体(ProGRP), 鳞状上皮细胞癌抗原(SCCAg), 人附睾蛋白4
(HE4) 水平与非小细胞肺癌(NSCLC) 患者病理特征的关系, 分析其对NSCLC 的临床诊断价值 …